Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahin Lockman

Showing results (111-120 of 268) with videos related to

Pageof 27
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 18, 2018
Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, BotswanaDeborah Kacanek, Paige L Williams, Gloria Mayondi, et al.
International Breastfeeding Journal|October 14, 2021
Lack of HIV RNA test result is a barrier to breastfeeding among women living with HIV in BotswanaGloria Katuta Mayondi, Aamirah Mussa, Rebecca Zash, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2025
Bone Mineral Content, Growth, and Renal Health of Infants With Perinatal Exposure to Maternal Dolutegravir Versus Efavirenz and Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide: The Randomized IMPAACT 2010 (VESTED) TrialTapiwa G Mbengeranwa, Lauren Ziemba, Sean S Brummel, et al.
Open Forum Infectious Diseases|August 12, 2021
The Impact of Syndromic Management of Vaginal Discharge Syndrome on Adverse Birth Outcomes in BotswanaChristina Fennell, Modeigi Diseko, Rebecca Zash, et al.
Journal of the International AIDS Society|March 7, 2018
A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and AustraliaTafireyi Marukutira, Mark Stoové, Shahin Lockman, et al.
AIDS (London, England)|December 20, 2015
In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in BotswanaKathleen M Powis, Laura Smeaton, Michael D Hughes, et al.
The Lancet. HIV|August 9, 2020
Rapid antiretroviral therapy initiation in the Botswana Combination Prevention Project: a quasi-experimental before and after studyRefeletswe Lebelonyane, Pamela Bachanas, Lisa Block, et al.
JCO Global Oncology|December 12, 2024
Access to and Utilization of Endocrine Therapy Among Breast Cancer Survivors in BotswanaJames R Wester, Rachel B Wagner, Bosa Motladiile, et al.
The Lancet. Global Health|May 13, 2022
Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in BotswanaEllen C Caniglia, Rebecca Zash, Sonja A Swanson, et al.
AIDS (London, England)|February 5, 2011
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialAndrea L Ciaranello, Shahin Lockman, Kenneth A Freedberg, et al.
Pageof 27

Showing results (111-120 of 268) with videos related to

Sort By:
Pageof 27
Journal of Acquired Immune Deficiency Syndromes (1999)|July 18, 2018
Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, BotswanaDeborah Kacanek, Paige L Williams, Gloria Mayondi, et al.
International Breastfeeding Journal|October 14, 2021
Lack of HIV RNA test result is a barrier to breastfeeding among women living with HIV in BotswanaGloria Katuta Mayondi, Aamirah Mussa, Rebecca Zash, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2025
Bone Mineral Content, Growth, and Renal Health of Infants With Perinatal Exposure to Maternal Dolutegravir Versus Efavirenz and Tenofovir Disoproxil Fumarate Versus Tenofovir Alafenamide: The Randomized IMPAACT 2010 (VESTED) TrialTapiwa G Mbengeranwa, Lauren Ziemba, Sean S Brummel, et al.
Open Forum Infectious Diseases|August 12, 2021
The Impact of Syndromic Management of Vaginal Discharge Syndrome on Adverse Birth Outcomes in BotswanaChristina Fennell, Modeigi Diseko, Rebecca Zash, et al.
Journal of the International AIDS Society|March 7, 2018
A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and AustraliaTafireyi Marukutira, Mark Stoové, Shahin Lockman, et al.
AIDS (London, England)|December 20, 2015
In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in BotswanaKathleen M Powis, Laura Smeaton, Michael D Hughes, et al.
The Lancet. HIV|August 9, 2020
Rapid antiretroviral therapy initiation in the Botswana Combination Prevention Project: a quasi-experimental before and after studyRefeletswe Lebelonyane, Pamela Bachanas, Lisa Block, et al.
JCO Global Oncology|December 12, 2024
Access to and Utilization of Endocrine Therapy Among Breast Cancer Survivors in BotswanaJames R Wester, Rachel B Wagner, Bosa Motladiile, et al.
The Lancet. Global Health|May 13, 2022
Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in BotswanaEllen C Caniglia, Rebecca Zash, Sonja A Swanson, et al.
AIDS (London, England)|February 5, 2011
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialAndrea L Ciaranello, Shahin Lockman, Kenneth A Freedberg, et al.
Pageof 27